← Leaderboards
Aaron J Goldenberg
Case Western Reserve University
$4,073,395
Attributed
$7,715,040
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,715,040 · 4
By mechanism
R01$7,283,290 · 3
R21$431,750 · 1
Top collaborators
- Kyle Bertram Brothers4 shared
- Erin Rothwell4 shared
- Beth A Tarini4 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Ronald Lee Hickman$3,257,778
- Kath Bogie$529
- Laura A Siminoff$15,542,153
- Maxwell J Mehlman$2,547,061
- Christian M Simon$1,853,523
Others in their field
Top investigators on “Policies”
- David R. Weir · University Of Michigan At Ann Arbor$391,103,270
- Christopher McKay · Battelle Memorial Institute$267,829,683
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
PoliciesInterviewResearch PersonnelRecommendationParentsNewborn InfantChildNeonatal ScreeningProgramsBiobankResourcesConsentRepositoryCollectionSamplingParticipantScreening ProgramNational Human Genome Research InstituteInstitutionProspectiveFocus GroupsFutureEthicsPrecision Medicine
Grant awards (14)
Emerging Challenges in NBS: Benefits and Harms of Receiving Uncertain Prognoses After NBS$722,480
R01 · FY2025 · HD
Implementing a Novel Consent Process for Biospecimen Research after Newborn Screening in Michigan Hospitals$638,477
R01 · FY2025 · HD
Emerging Challenges in NBS: Benefits and Harms of Receiving Uncertain Prognoses After NBS$717,365
R01 · FY2024 · HD
Implementing a Novel Consent Process for Biospecimen Research after Newborn Screening in Hospitals Serving Diverse Patients$636,302
R01 · FY2024 · HD
Emerging Challenges in NBS: Benefits and Harms of Receiving Uncertain Prognoses After NBS$722,727
R01 · FY2023 · HD
Implementing a Novel Consent Process for Biospecimen Research after Newborn Screening in Hospitals Serving Diverse Patients$654,140
R01 · FY2023 · HD
Emerging Challenges in NBS: Benefits and Harms of Receiving Uncertain Prognoses After NBS$787,682
R01 · FY2022 · HD
Implementing a Novel Consent Process for Biospecimen Research after Newborn Screening in Hospitals Serving Diverse Patients$693,250
R01 · FY2022 · HD
Addressing Ethical Challenges in Networked Biorepositories$433,546
R01 · FY2019 · HG
Addressing Ethical Challenges in Networked Biorepositories$417,683
R01 · FY2018 · HG
Addressing Ethical Challenges in Networked Biorepositories$420,368
R01 · FY2017 · HG
Addressing Ethical Challenges in Networked Biorepositories$439,270
R01 · FY2016 · HG
Biobanking at Birth: Parental Attitudes towards the Use of Perinatal Samples$196,250
R21 · FY2013 · HG · contact PI
Biobanking at Birth: Parental Attitudes towards the Use of Perinatal Samples$235,500
R21 · FY2012 · HG · contact PI